News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Myeloma Paper of the Day, May 2nd, suggested by Robert Orlowski
May 2, 2025, 09:25

Myeloma Paper of the Day, May 2nd, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: dFLC over 180 mg/L may no longer holds prognostic value in era of CyBorD/DaraCyBorD-based AL amyloidosis therapy and question utility of Mayo 2012 staging system in the era of highly effective chemo-immunotherapies.”

Title: Predictive Value of Free Light Chain Burden in Patients with AL Amyloidosis Treated with Bortezomib-Based Regimens

Authors: Brendan Saunders, Foteini Theodorakakou, Despina V Fotiou, Samuel Boullt, Benjamin Evans, Meletios Athanasios Dimopoulos, Efstathios Kastritis, Giada Bianchi.

You can read the Full Article on Blood Advances.

Myeloma Paper of the Day, May 2nd, suggested by Robert Orlowski

More posts featuring Robert Orlowski.

AL Amyloidosis Benjamin Evans Brendan Saunders cancer Despina V Fotiou Efstathios Kastritis Foteini Theodorakakou Giada Bianchi Meletios-Athanasios Dimopoulos Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski Samuel Boullt
Special Coverage
Blog
Jul 6, 2025, 02:27
A Public Hearing to Better Meet the Needs of Underserved Communities - European Cancer Organisation
Insight
Jul 5, 2025, 20:31
Diego A. Díaz García: Subclonal Immune Evasion in NSCLC
Blog
Jul 5, 2025, 20:15
Petros Grivas is Receiving 2025 Young Investigator Award
Blog
Jul 5, 2025, 20:00
Roberto Ferrara: Winter of Cancer Immunotherapy is Here
Blog
Jul 5, 2025, 19:42
Mario Balsa: TIME May Not Just Tell the Story - It Could Write the Prognosis STAR-01 at ESMOGI25
Blog
Jul 5, 2025, 19:18
Amol Akhade: CRC Screening Face-Off: Stool vs Blood
Blog
Jul 5, 2025, 18:53
Vivek Subbiah: How Clinical Trials Offer Hope for Those Facing Limited Options
Blog
Jul 5, 2025, 18:52
Saddened to Announce the Passing of Dr. Samantha Garza
Blog
Jul 5, 2025, 18:44
Because in a World Full of Opportunities, There’s No Time to Stop - CancerWorld
Blog
Jul 5, 2025, 18:38
Wongel Tsegaye: Crafting African Solutions for African Challenges
Blog
Jul 5, 2025, 18:26
Francisco J. Esteva: My New YouTube Channel Translates Breakthrough Cancer Care Into Plain, Evidence-based Guidance
Blog
Jul 5, 2025, 18:18
Don't Miss Out on the 2nd National Cancer Summit - National Cancer Institute of Kenya